Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure
✍ Scribed by Ibrahim Tek; Onder Arslan; Mutlu Arat; Erol Ayyıldız; Meltem Tol; Mehmet Oral; Osman Ilhan
- Book ID
- 116928331
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 248 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1473-0502
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Human albumin is commonly used as a replacement fluid in therapeutic plasma exchange (pe). in order to determine whether pentaspan (pes), a synthetic low molecular weight starch solution, might be an effective substitute, we compared albumin with pes in 12 patients with myasthenia gr
We compared the safety, effect on plasma proteins, and contribution to hypocalcemic toxicity of 10% pentastarch vs. 5% albumin in plasma exchange. Thirty-two neurology patients underwent 161 plasma exchange procedures. Subjects were randomized to receive either 10% pentastarch (n ס 17) or 5% album
## Abstract Therapeutic plasma exchange (TPE) is an effective treatment in Myasthenia gravis (MG) and Guillain‐Barré syndrome (GBS) and 5% human albumin is the replacement fluid of choice; however, it is expensive. More recently, it has been suggested that starch is a safe and cheaper choice to hum